Search Results

Booz Allen Hamilton announced it was awarded a seven-year, $419 million contract with the National Science Foundation for Information Technology Mission Application Support.

The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.

Theromics Inc., a leading developer of products for the interventional oncology and interventional radiology markets, has announced the receipt of a $1M STTR Phase II grant from the National Science Foundation.

The Foundation for the National Institutes of Health announces that Love Collins, III, has joined as Vice President of Advancement.

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announces that it will be a Bronze Sponsor for the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 national conference in Albuquerque, New Mexico from June 28-30, 2024.

The National Kidney Foundation is applauding a move by Congress to increase access to care and improve outcomes for some patients on dialysis.

As March approaches, the National Kidney Foundation is gearing up to observe National Kidney Month, a crucial time dedicated to raising awareness about kidney health and chronic kidney disease.

The Foundation for the National Institutes of Health announces two additions to the FNIH Board of Directors: James W. Down, former Vice Chairman of Mercer Management Consulting, and Perry Steiner, Chairman and CEO of Xactus.

Nanopath Inc. announced today that it was awarded $4 million in federal funding.

A new analysis of a study comparing two commonly used medications, chlorthalidone and hydrochlorothiazide, is set to be presented as a late-breaking presentation at the annual 2024 National Kidney Foundation Spring Clinical Meetings.